Transplantation Market Trends

ID: MRFR/HC/10345-HCR

200 Pages

Rahul Gotadki

October 2025

Transplantation Market Research Report By Organ Type (Kidney, Liver, Heart, Lung, Pancreas), By Transplantation Type (Deceased Donor Transplantation, Living Donor Transplantation, Xenotransplantation), By Application (Solid Organ Transplantation, Stem Cell Transplantation, Tissue Transplantation), By End-use (Hospitals, Transplant Centers, Specialty Clinics), and By Regional (North America, Eur...

Summary Table of Contents Segmentation Download PDF

Market Trends

Key Emerging Trends in the Transplantation Market

Transplantation is an area going through a critical shift because of innovative progressions, organ shortage concerns, and customized medication. Especially with regards to kidney transfers, automated helped surgeries are turning out to be more predominant, upgrading obtrusiveness, exactness, and patient results. The shortage of organs represents a critical obstruction in the field of transplantation, provoking the advancement of xenotransplantation — a feasible elective that includes pig-to-human transfers — with an end goal to conquer resistant hindrances and work on the wellbeing of transfers. Transplantation is going through a change because of the impact of customized medication, which focuses on immunosuppressive treatments custom-made to the hereditary profiles of relocate beneficiaries with an end goal to further develop immunosuppression, decline unfavourable impacts, and increment relocate achievement. Perfusion machines are progressively being used in organ conservation and transplantation to further develop relocate results and contributor organ reasonability through the alteration of organ quality and the extension of the giver pool. Headways in organ obtainment and portion arrangements are forming the transplantation market. These upgrades envelop developments in matching calculations, portion arrangements, and geological sharing systems. The general objectives are to improve effectiveness and value, amend access incongruities, and upgrade the impact of giver organs. Post-relocate care is being improved through the execution of telemedicine and remote observing, which are reinforcing patient administration and ends. Virtual stages work with the remote screening of beneficiaries, assessment of boundaries, and conveyance of convenient intercessions by medical services suppliers, which is predictable with the expansive reception of telehealth arrangements. High level imaging and demonstrative procedures are changing pre-relocate assessment and organ valuation, consequently working with post-relocate inconveniences and working on the exactness of organ choice. This peculiarity mirrors a commitment to upgrading pre-relocate assessment strategies and ensuring the most reasonable match among givers and beneficiaries. The execution of refined imaging and demonstrative strategies is progressing pre-relocate assessment and organ evaluation. Using atomic diagnostics, biomarker testing, and high-goal imaging to choose organs all the more unequivocally decreases the gamble of difficulties following transplantation. This tendency exhibits a pledge to propelling the pre-relocate assessment process and guaranteeing the most reasonable match among benefactors and beneficiaries.

Market Highlights

Author

Rahul Gotadki

Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

FAQs

What is the current valuation of the Transplantation Market as of 2024?

The Transplantation Market was valued at 16.86 USD Billion in 2024.

What is the projected market valuation for the Transplantation Market in 2035?

The market is projected to reach 45.77 USD Billion by 2035.

What is the expected CAGR for the Transplantation Market during the forecast period 2025 - 2035?

The expected CAGR for the Transplantation Market during 2025 - 2035 is 9.5%.

Which organ type segment is projected to have the highest valuation by 2035?

The Kidney segment is projected to reach 13.0 USD Billion by 2035.

How does the valuation of Living Donor Transplantation compare to Deceased Donor Transplantation by 2035?

By 2035, Living Donor Transplantation is expected to reach 20.1 USD Billion, surpassing Deceased Donor Transplantation at 17.2 USD Billion.

What are the projected valuations for Solid Organ Transplantation and Stem Cell Transplantation by 2035?

Solid Organ Transplantation is projected to reach 22.5 USD Billion, while Stem Cell Transplantation is expected to reach 10.5 USD Billion by 2035.

Which end-use segment is anticipated to have the highest growth by 2035?

The Hospitals segment is anticipated to grow to 17.2 USD Billion by 2035.

Who are the key players in the Transplantation Market?

Key players include United Therapeutics Corporation, Organogenesis Inc., Astellas Pharma Inc., and AbbVie Inc.

What is the projected valuation for the Pancreas organ type segment by 2035?

The Pancreas organ type segment is projected to reach 8.77 USD Billion by 2035.

What is the expected growth trend for Tissue Transplantation by 2035?

Tissue Transplantation is expected to grow to 12.77 USD Billion by 2035.

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

As per MRFR analysis, the Transplantation Market Size was estimated at 16.86 USD Billion in 2024. The Transplantation industry is projected to grow from 18.47 USD Billion in 2025 to 45.77 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 9.5 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The transplantation market is poised for growth driven by technological advancements and increased awareness.

Technological advancements in transplantation are enhancing surgical outcomes and patient care.
North America remains the largest market, while Asia-Pacific is emerging as the fastest-growing region.
Kidney transplantation holds the largest market share, whereas liver transplantation is experiencing rapid growth.
Rising incidence of organ failure and increased investment in research and development are key drivers of market expansion.

Market Size & Forecast

2024 Market Size	16.86 (USD Billion)
2035 Market Size	45.77 (USD Billion)
CAGR (2025 - 2035)	9.5%
Largest Regional Market Share in 2024	North America

Major Players

United Therapeutics Corporation (US), Organogenesis Inc. (US), Astellas Pharma Inc. (JP), AbbVie Inc. (US), Medtronic plc (IE), Hoffmann-La Roche Ltd (CH), Sandoz International GmbH (CH), NantKwest Inc. (US), TransMedics Inc. (US)

Market Trends

The Transplantation Market is currently experiencing a dynamic evolution, driven by advancements in medical technology and an increasing demand for organ transplants. Innovations in surgical techniques, such as minimally invasive procedures, are enhancing patient outcomes and reducing recovery times. Furthermore, the integration of artificial intelligence and machine learning in donor-recipient matching processes appears to improve the efficiency and success rates of transplants. This technological progress, coupled with a growing awareness of organ donation, suggests a potential increase in transplant procedures globally. In addition, the Transplantation Market is influenced by regulatory frameworks and ethical considerations surrounding organ donation. Governments and health organizations are actively working to establish guidelines that ensure equitable access to transplantation services. This focus on ethical practices may lead to enhanced public trust and participation in organ donation programs. As the market continues to evolve, collaboration among healthcare providers, researchers, and policymakers will likely play a crucial role in addressing challenges and optimizing transplant outcomes.

Technological Advancements in Transplantation

Recent innovations in medical technology are reshaping the Transplantation Market. Enhanced surgical techniques, including robotic-assisted surgeries, are facilitating more precise and less invasive procedures. Additionally, the use of advanced imaging technologies aids in better pre-operative planning and post-operative monitoring, potentially leading to improved patient outcomes.

Increased Focus on Organ Donation Awareness

There is a growing emphasis on raising awareness about organ donation, which is crucial for the sustainability of the Transplantation Market. Campaigns aimed at educating the public about the importance of organ donation are likely to foster a culture of giving, thereby increasing the number of available organs for transplantation.

Regulatory Developments and Ethical Considerations

The Transplantation Market is also shaped by evolving regulatory frameworks and ethical considerations. Governments and health organizations are working to create policies that ensure fair access to transplantation services. This focus on ethical practices may enhance public trust and encourage more individuals to participate in organ donation initiatives.

The Global Transplantation Market is poised for expansion, driven by advancements in surgical techniques and an increasing emphasis on organ donation awareness.

U.S. Department of Health and Human Services

Transplantation Market Market Drivers

Rising Incidence of Organ Failure

The increasing prevalence of chronic diseases such as diabetes and hypertension is contributing to a higher incidence of organ failure, thereby driving the Transplantation Market. According to recent statistics, the number of patients requiring organ transplants is projected to rise significantly, with estimates suggesting that by 2025, the demand for kidney transplants alone may exceed 100,000 annually. This surge in demand places immense pressure on healthcare systems to enhance organ procurement and transplantation processes. As a result, healthcare providers are likely to invest more in transplantation technologies and services, which could further stimulate growth in the Transplantation Market. The need for effective treatment options for organ failure is thus a critical driver, as it compels stakeholders to innovate and expand their offerings in the transplantation sector.

Growing Awareness of Organ Donation

Public awareness campaigns aimed at promoting organ donation are playing a pivotal role in shaping the Transplantation Market. As societies become more informed about the benefits of organ donation, the number of registered donors is likely to increase. Recent surveys indicate that a significant percentage of individuals express willingness to donate organs, yet many remain unregistered. Efforts to bridge this gap through educational initiatives and community outreach are essential. The increase in organ availability directly correlates with the growth of the Transplantation Market, as more organs become accessible for transplantation, thereby improving patient outcomes and reducing waiting times.

Advancements in Transplantation Techniques

Innovations in surgical techniques and post-operative care are transforming the landscape of the Transplantation Market. Techniques such as minimally invasive surgery and robotic-assisted procedures are enhancing patient outcomes and reducing recovery times. Furthermore, advancements in immunosuppressive therapies are improving graft survival rates, which is crucial for patient satisfaction and long-term success. Data indicates that the five-year survival rate for kidney transplants has improved to over 90% in many regions, reflecting the positive impact of these advancements. As healthcare providers adopt these new technologies, the Transplantation Market is likely to experience accelerated growth, driven by the demand for safer and more effective transplantation options.

Increased Investment in Research and Development

The Transplantation Market is witnessing a surge in investment directed towards research and development initiatives. Governments and private entities are recognizing the importance of advancing transplantation science, leading to increased funding for innovative therapies and technologies. For instance, the development of bioengineered organs and xenotransplantation is gaining traction, with several research projects underway. This influx of capital is expected to yield breakthroughs that could revolutionize the field, potentially addressing the organ shortage crisis. As new solutions emerge, the Transplantation Market may expand significantly, attracting more stakeholders and enhancing the overall landscape of organ transplantation.

Regulatory Support for Transplantation Practices

The regulatory environment surrounding organ transplantation is evolving, with governments implementing supportive policies to enhance transplantation practices. These regulations aim to streamline the organ procurement process and ensure ethical standards are maintained. For example, initiatives to establish national organ registries and improve allocation systems are gaining momentum. Such regulatory frameworks are crucial for fostering trust among the public and healthcare providers, which in turn can lead to increased participation in organ donation programs. As these supportive measures take effect, the Transplantation Market is likely to benefit from a more robust infrastructure, facilitating growth and improving access to transplantation services.

Market Segment Insights

By Organ Type: Kidney (Largest) vs. Liver (Fastest-Growing)

In the transplantation market, the organ type segment showcases a diverse distribution of shares among various organs. The kidney maintains its status as the largest segment, driven by the high prevalence of kidney-related diseases and growing demand for kidney transplants. Liver transplants, on the other hand, have emerged as a significant growth area, spurred by increasing liver disease incidences and advancements in transplant techniques.

Kidney (Dominant) vs. Liver (Emerging)

Kidney transplants dominate the transplantation market due to their extensive demand driven by chronic kidney diseases and favorable outcomes. This segment is characterized by a well-established donor-recipient matching process that enhances transplant success rates. Conversely, the liver transplant segment is considered emerging, experiencing rapid growth fueled by rising alcohol-related liver diseases and improved surgical methods. Despite being smaller than kidney transplants, liver procedures are becoming increasingly common, highlighting evolving strategies to address critical shortages in organ availability.

By Transplantation Type: Deceased Donor Transplantation (Largest) vs. Living Donor Transplantation (Fastest-Growing)

The transplantation market is primarily dominated by Deceased Donor Transplantation, holding the largest share among the methods utilized for organ procurement. This method remains prevalent due to a well-established infrastructure and protocols formed over years of practice, with hospitals, transplant centers, and organ procurement organizations effectively collaborating to facilitate the process. Living Donor Transplantation, while smaller in market share, is experiencing a notable uptick in acceptance and prevalence as medical advancements reduce risks for both donors and recipients, thus expanding its representation.

Deceased Donor Transplantation (Dominant) vs. Living Donor Transplantation (Emerging)

Deceased Donor Transplantation stands as the cornerstone of organ transplants, leveraging organs donated posthumously. This method boons from a robust donor framework, regulatory standards, and considerable public awareness, fostering trust within potential donor families. In contrast, Living Donor Transplantation is gaining traction through advocacy campaigns and growing success stories showcasing the benefits of this option. Recent improvements in surgical techniques, paired with the increasing compatibility of organ matches, are positioning this method as a key player. The balance between Deceased Donor's established dominance and Living Donor's emerging narrative shapes the future trajectory of the transplantation market.

By Application: Solid Organ Transplantation (Largest) vs. Stem Cell Transplantation (Fastest-Growing)

The transplantation market showcases a diverse array of applications, with solid organ transplantation holding the largest market share. This segment encompasses vital procedures such as kidney, liver, heart, and lung transplants. Meanwhile, stem cell transplantation, although smaller in immediate market share, is recognized as the fastest-growing area thanks to advancements in regenerative medicine and increasing acceptance among healthcare providers and patients. Tissue transplantation follows, serving as a supportive application in enhancing surgical outcomes and improving patient recovery processes. The growth trends in the transplantation market are being driven by several factors, including increased organ donor awareness, technological advancements in surgical techniques, and improved post-transplant care. Additionally, stem cell transplantation is seeing a rapid rise due to innovative therapies in treating various malignancies and hematological disorders, which bolster its position as a preferred treatment option. Efforts to expand donor registries and enhance transplant logistics also underscore the optimistic growth forecast for this market segment.

Solid Organ Transplantation (Dominant) vs. Tissue Transplantation (Emerging)

Solid organ transplantation remains the dominant force in the transplantation market, primarily due to its critical nature in life-saving procedures and well-established medical practices. It encompasses extensive networks for organ donation and transplantation, ensuring a robust operational framework. On the other hand, tissue transplantation, while considered emerging, plays an increasingly vital role in enhancing surgical procedures and recovery. This segment focuses on the transplantation of skin, bone, and corneal tissues, driven by the need for reconstructive surgery and trauma care. Innovations in tissue preservation and transplantation techniques are set to elevate its market presence, potentially transforming it into an indispensable part of patient recovery and rehabilitation processes within the broader transplantation landscape.

By End-use: Hospitals (Largest) vs. Transplant Centers (Fastest-Growing)

In the Transplantation Market, the distribution of market share among various end-use segments reveals that hospitals are the dominant players, significantly contributing to the overall demand for transplantation services. They serve as primary facilities offering a comprehensive range of surgical and post-operative care, establishing a strong foundation for market share. Conversely, transplant centers, while currently smaller in share, are experiencing rapid growth, driven by increasing patient awareness and advancements in transplantation techniques.

Hospitals (Dominant) vs. Transplant Centers (Emerging)

Hospitals play a crucial role in the transplantation market as dominant facilities equipped with specialized teams to handle complex surgeries and patient care. Their extensive resources and established protocols contribute to high patient throughput, thereby solidifying their position in this sector. In contrast, transplant centers, characterized as emerging players, are gaining recognition for their focused expertise in transplantation procedures. With specialized staff and advanced technology, these centers are witnessing a surge in patient referrals, driven by a rising demand for tailored transplant solutions and improved patient outcomes.

Get more detailed insights about Transplantation Market Research Report—Global Forecast till 2035

Regional Insights

North America : Leading Innovation and Research

North America is the largest market for transplantation, holding approximately 45% of the global share. The region benefits from advanced healthcare infrastructure, significant R&D investments, and a growing demand for organ transplants driven by increasing chronic diseases. Regulatory support from agencies like the FDA further catalyzes market growth, ensuring safety and efficacy in transplantation procedures. The United States is the primary player in this market, with key companies such as United Therapeutics Corporation and AbbVie Inc. leading the charge. The competitive landscape is characterized by innovation in organ preservation technologies and immunosuppressive therapies. Canada also plays a significant role, contributing to the overall market dynamics with its robust healthcare policies and research initiatives.

Europe : Regulatory Framework and Growth

Europe is the second-largest market for transplantation, accounting for around 30% of the global share. The region is witnessing growth driven by increasing organ donation rates and advancements in transplantation technologies. Regulatory frameworks established by the European Medicines Agency (EMA) are pivotal in ensuring the safety and efficacy of transplantation products, fostering a conducive environment for market expansion. Leading countries in this region include Germany, France, and the UK, which are home to several key players like Hoffmann-La Roche Ltd and Astellas Pharma Inc. The competitive landscape is marked by collaborations between public and private sectors to enhance organ donation and transplantation processes. Innovative therapies and improved surgical techniques are also contributing to the market's growth trajectory.

Asia-Pacific : Rapid Growth and Opportunities

Asia-Pacific is an emerging powerhouse in the transplantation market, holding approximately 20% of the global share. The region is experiencing rapid growth due to increasing healthcare expenditures, rising awareness about organ donation, and advancements in medical technologies. Countries like Japan and Australia are leading the way, supported by favorable government policies and initiatives aimed at improving organ transplant rates. Japan is particularly notable for its advanced healthcare system and significant investments in biotechnology. The competitive landscape features key players such as Astellas Pharma Inc. and Medtronic plc, which are actively involved in developing innovative transplantation solutions. The region's market dynamics are further enhanced by collaborations between healthcare providers and research institutions to address the growing demand for organ transplants.

Middle East and Africa : Emerging Market with Challenges

The Middle East and Africa region is gradually emerging in the transplantation market, holding about 5% of the global share. Growth is driven by increasing healthcare investments and a rising prevalence of chronic diseases necessitating organ transplants. However, challenges such as limited organ donation awareness and regulatory hurdles hinder faster market development. Countries like South Africa and the UAE are making strides in improving transplantation services and infrastructure. South Africa is a leader in organ transplantation within the region, supported by initiatives from the Organ Donation Foundation. The competitive landscape is evolving, with local and international players seeking to establish a foothold. Efforts to enhance public awareness and improve healthcare policies are crucial for unlocking the region's full potential in the transplantation market.

Key Players and Competitive Insights

The Transplantation Market is currently characterized by a dynamic competitive landscape, driven by advancements in medical technology, increasing organ transplant demand, and a growing emphasis on personalized medicine. Key players such as United Therapeutics Corporation (US), Astellas Pharma Inc. (JP), and AbbVie Inc. (US) are strategically positioned to leverage these trends. United Therapeutics Corporation (US) focuses on innovation in organ preservation and transplantation therapies, while Astellas Pharma Inc. (JP) emphasizes partnerships to enhance its transplant portfolio. AbbVie Inc. (US) is actively pursuing mergers and acquisitions to expand its capabilities in immunosuppressive therapies, collectively shaping a competitive environment that prioritizes technological advancement and strategic collaborations.

In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market appears moderately fragmented, with a mix of established players and emerging companies vying for market share. The collective influence of these key players is significant, as they drive innovation and set industry standards, thereby shaping the overall market structure.

In August 2025, United Therapeutics Corporation (US) announced a groundbreaking partnership with a leading biotechnology firm to develop a novel organ preservation solution. This strategic move is expected to enhance the viability of transplanted organs, potentially increasing transplant success rates and addressing the critical shortage of available organs. Such innovations may position United Therapeutics as a leader in the transplantation space, reinforcing its commitment to improving patient outcomes.

In September 2025, Astellas Pharma Inc. (JP) launched a new immunosuppressive drug aimed at reducing organ rejection rates in kidney transplant patients. This product introduction not only strengthens Astellas' market position but also reflects its ongoing commitment to research and development in transplantation therapies. The launch is likely to enhance patient care and solidify Astellas' reputation as a key player in the transplantation market.

In July 2025, AbbVie Inc. (US) completed the acquisition of a smaller biotech firm specializing in cell therapy for organ transplantation. This acquisition is strategically significant as it expands AbbVie's capabilities in regenerative medicine, potentially allowing for more effective treatments in the transplantation arena. The integration of these technologies could lead to innovative solutions that address the challenges of organ rejection and improve long-term transplant success.

As of October 2025, the Transplantation Market is witnessing trends such as digitalization, sustainability, and the integration of artificial intelligence in patient management and organ matching processes. Strategic alliances among key players are increasingly shaping the competitive landscape, fostering innovation and collaboration. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability, as companies strive to meet the growing demands of the transplantation market.

Key Companies in the Transplantation Market market include

Industry Developments

In August 2024, Getinge made its entrance in the rapidly expanding organ preservation and transportation industry when it announced that it would acquire Paragonix Technologies for about USD 477 million.

By utilizing Getinge's extensive worldwide commercial infrastructure and incorporating Paragonix's cutting-edge digital cooling and monitoring technologies, this calculated step expands Getinge's portfolio in the areas of heart, lung, kidney stones, liver, and pancreatic transplants.

The company's growth as a specialized leader in organ transplant logistics was highlighted in October 2023 when Paragonix Technologies opened its new U.S. headquarters in Waltham, Massachusetts. By successfully using its LIVERguard donor liver preservation technology for the first time in an extended-distance transplant to Florida in September 2023, Paragonix reached a significant milestone in Puerto Rico.

The GUARDIAN Registry clinical research, which included over 500 heart transplant recipients, also reported in September 2023 that the use of Paragonix preservation technology reduced Primary Graft Dysfunction by 67%. The FDA approved Paragonix's next-generation donor lung preservation platform, BAROguard, in August 2023.

This platform guarantees regulated airway pressure and temperature during transportation. In May 2025, TransMedics Group revealed its active involvement in the ISHLT Scientific Sessions, showed a 48% year-over-year rise in Q1 sales to USD 143.5 million, and announced plans to construct a design center and production facility in Mirandola, Italy.

The first patient in a Phase 2 study of Triplex, a CMV vaccine intended for liver transplant recipients and supported by NIH/NIAID, was dosed in May 2024 by Helocyte, a division of Fortress Biotech.

Future Outlook

Transplantation Market Future Outlook

The Transplantation Market is projected to grow at a 9.5% CAGR from 2024 to 2035, driven by advancements in technology, increasing organ donation rates, and rising healthcare expenditures.

New opportunities lie in:

Development of personalized immunosuppressive therapies
Expansion of telehealth services for post-transplant care
Investment in bioprinting technologies for organ creation

By 2035, the Transplantation Market is expected to achieve substantial growth, reflecting enhanced healthcare capabilities and innovation.

Market Segmentation

Transplantation Market End-use Outlook

Hospitals
Transplant Centers
Specialty Clinics

Transplantation Market Organ Type Outlook

Kidney
Liver
Heart
Lung
Pancreas

Transplantation Market Application Outlook

Solid Organ Transplantation
Stem Cell Transplantation
Tissue Transplantation

Transplantation Market Transplantation Type Outlook

Deceased Donor Transplantation
Living Donor Transplantation
Xenotransplantation

Report Scope

MARKET SIZE 2024	16.86(USD Billion)
MARKET SIZE 2025	18.47(USD Billion)
MARKET SIZE 2035	45.77(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	9.5% (2024 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Billion
Key Companies Profiled	Market analysis in progress
Segments Covered	Market segmentation analysis in progress
Key Market Opportunities	Advancements in organ preservation techniques enhance transplant viability and expand donor organ availability in the Transplantation Market.
Key Market Dynamics	Technological advancements and regulatory changes drive innovation and competition in the transplantation market.
Countries Covered	North America, Europe, APAC, South America, MEA